by Dr Simone | Mar 28, 2020 | Big Pharma, Bioweapon, CORONAVIRUS, COVID-19, Dr Simone, Myocarditis, The Simone Report
I asked myself several questions.
WHY is the current CoVID-19 coronavirus (SARS-Cov-2) so powerful, and so virulent?
WHY does it preferentially seek out people who have high ACE2 docking sites on their cells due to their prescription medicines or diseases, obesity, smoking?
WHY does it cause tremendous immune system dysfunction in many infected people, similar to what we see with AIDS patients?
And Who funded this?
by Dr Simone | Mar 26, 2020 | ACE2, Big Pharma, Bioweapon, Charles B SimoneMD, CORONAVIRUS, COVID-19, Infections, Inflammation, Myocarditis
I asked myself several questions.
WHY is the current CoVID-19 coronavirus (SARS-Cov-2) so powerful, and so virulent?
WHY does it preferentially seek out people who have high ACE2 docking sites on their cells due to their prescription medicines or diseases, obesity, smoking?
WHY does it cause tremendous immune system dysfunction in many infected people, similar to what we see with AIDS patients?
And Who funded this?
by Dr Simone | Mar 21, 2020 | Charles B SimoneMD, CORONAVIRUS
DRUGS INCREASE ACE2 THAT IS NEEDED BY SARS-CoV-2 (COVID-19 Coronavirus) TO ATTACH AND INFECT CELLS of the lung, intestine, kidney, blood vessel.
The more ACE2, the more infection. This may be the reason why the elderly who are treated with these drugs, have a greater risk of death / severe side effects
by Dr Simone | Mar 10, 2020 | DEFEND YOURSELF, Immune System, Infections, Inflammation, Sinus Hygiene, Terror Attacks
Defend Yourself From a Viral Attack – a plan that you can implement.
by Dr Simone | Mar 7, 2020 | Charles B SimoneMD, Health Policy, Healthcare Costs
A new study shows that adults are protected without booster shots against tetanus and diphtheria for at least 30 years after getting the standard childhood vaccination shots. The United Kingdom and other countries do not recommend adult booster shots at all. Considering the number of adults scheduled to get booster shots at the current recommended 10 year interval, the authors of the study estimate a $280 million health care cost savings each year in the U.S. if the booster schedule were changed to at least the 30 year interval.